Smruthi Organics Limited (SMRUTHIORG) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE172E01011
Key metrics
- Market Cap
- ₹177 Cr
- P/E Ratio
- 23.85
- EPS
- 6.47
- Book Value
- 64.22
- P/B Ratio
- 2.33
- ROE
- 4.66%
- ROCE
- 8.45%
- Debt / Equity
- 0.12
- Net Margin
- 3.4%
- Revenue Growth
- -19.15%
- Profit Growth
- -3.85%
- Dividend Yield
- 1.06%
- 52W High
- ₹164.00
- 52W Low
- ₹95.00
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Smruthi Organics Limited
Smruthi Organics Limited manufactures and markets active pharmaceutical ingredient (API) products to India. The company operates through Bulk Drugs and Drugs Intermediates (API), and Formulation segments. The company provides API for cardiovascular, such as amlodipine besilate, losartan potassium, telmisartan, s - amlodipine besilate, s - amlodipine malelate, and valsartan; for anti diabetic, which comprises metformin HCL, vildagliptin, teneligliptin, and dapagliflozin; and for anti infectives that consists of diloxanide furoate, norfloxacin, and pefloxacin mesylate, as well as ticagrelor for anti platelets. It also offers drug intermediates, such as amlodipine base, s-amlodipine base, and phthaloyl amlodipine. In addition, the company is developing empagliflozin for anti-diabetics; and apixaban and rivaroxaban for anti-platelets. It also exports its products. The company was incorporated in 1989 and is headquartered in Solapur, India.
- Headquarters
- Solapur, India
- Employees
- 261
- Promoter Holding
- 66.88%
The full Smruthi Organics Limited analysis
Create a free account to open the complete SMRUTHIORG deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.